Top 10 Generic Drug Raw Material & Excipient Suppliers in Germany

Robert Gultig

5 January 2026

Top 10 Generic Drug Raw Material & Excipient Suppliers in Germany

User avatar placeholder
Written by Robert Gultig

5 January 2026

Introduction:

The pharmaceutical industry in Germany is known for its high-quality generic drugs and raw materials. With a strong focus on innovation and quality control, Germany has become a key player in the global pharmaceutical market. In recent years, the demand for generic drugs and raw materials has been on the rise, driven by factors such as increasing healthcare costs and the need for affordable medications. According to recent statistics, Germany is one of the top producers of generic drugs in Europe, with a production volume of over 10 billion units per year.

Top 10 Generic Drug Raw Material & Excipient Suppliers in Germany:

1. Merck KGaA
– Market Share: 15%
– Merck KGaA is a leading supplier of raw materials and excipients for the pharmaceutical industry in Germany. With a strong focus on research and development, the company is known for its high-quality products and innovative solutions.

2. BASF SE
– Market Share: 12%
– BASF SE is another key player in the German pharmaceutical market, providing a wide range of raw materials and excipients for generic drug manufacturers. The company’s products are known for their reliability and consistency.

3. Evonik Industries AG
– Market Share: 10%
– Evonik Industries AG is a major supplier of raw materials and excipients for the pharmaceutical industry in Germany. The company’s products are widely used in the production of generic drugs due to their high quality and performance.

4. Boehringer Ingelheim
– Market Share: 8%
– Boehringer Ingelheim is a well-known pharmaceutical company in Germany, also supplying raw materials and excipients for generic drug manufacturers. The company’s products are highly regarded for their efficacy and safety.

5. Bayer AG
– Market Share: 7%
– Bayer AG is a global pharmaceutical company with a significant presence in the German market. The company’s raw materials and excipients are widely used in the production of generic drugs, known for their high quality and purity.

6. Lonza Group
– Market Share: 6%
– Lonza Group is a Swiss-based company with a strong presence in the German pharmaceutical market. The company provides a wide range of raw materials and excipients for generic drug manufacturers, known for their reliability and performance.

7. Sigma-Aldrich
– Market Share: 5%
– Sigma-Aldrich is a leading supplier of raw materials and excipients for the pharmaceutical industry in Germany. The company’s products are highly regarded for their quality and consistency, making them a popular choice among generic drug manufacturers.

8. Roche
– Market Share: 4%
– Roche is a Swiss multinational healthcare company with a significant presence in the German pharmaceutical market. The company provides high-quality raw materials and excipients for generic drug manufacturers, known for their innovation and reliability.

9. Novartis
– Market Share: 3%
– Novartis is another Swiss multinational pharmaceutical company with a strong presence in Germany. The company’s raw materials and excipients are widely used in the production of generic drugs, known for their quality and performance.

10. AstraZeneca
– Market Share: 2%
– AstraZeneca is a British-Swedish multinational pharmaceutical company with a presence in the German market. The company’s raw materials and excipients are known for their high quality and reliability, making them a popular choice among generic drug manufacturers.

Insights:

The pharmaceutical industry in Germany is expected to continue growing in the coming years, driven by factors such as increasing demand for generic drugs and raw materials. With a strong focus on quality and innovation, German companies are well-positioned to meet the needs of the global market. According to recent forecasts, the market for generic drugs in Germany is projected to reach over €20 billion by 2025, indicating significant growth opportunities for suppliers of raw materials and excipients. As the industry continues to evolve, companies that prioritize quality, reliability, and innovation will be best positioned to succeed in the competitive market.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →